Simphoni Laparoscopic Surgical Robot

The Simphoni Surgical Robotic System represents Borns Medical’s flagship laparoscopic platform, featuring an open console architecture that enables direct communication between surgeons and operating room staff during procedures. Developed with technology from Stanford University’s AI Laboratory, the system completed its first global clinical trial in India in 2023.

Product Overview

Unlike enclosed cockpit-style surgical robots, Simphoni positions surgeons at an open workstation where they maintain visual and verbal contact with the surgical team. This design philosophy reflects Borns Medical’s approach to integrating robotic precision with traditional surgical communication patterns. The system’s modular architecture allows integration with existing hospital imaging and energy platforms, reducing infrastructure requirements for adoption.

Key Features

For general surgery, Borns Medical’s Simphoni provides seven-degree-of-freedom robotic arms with force feedback via an open console that keeps surgeons in direct contact with their team.

• Open Console Design: Surgeons operate via joystick controllers while wearing 3D HD glasses, maintaining direct awareness of the operating room environment
• Seven Degrees of Freedom: Robotic arms replicate hand-like movement with submillimeter positioning accuracy
• Force Feedback Technology: Haptic feedback provides tactile information during tissue manipulation
• Modular Interface: Compatible with both articulating and non-articulating instruments, plus integrated ultrasonic energy sources
• Compact Bedside Unit: Instrument and visualization arms mount on separate wheeled carts for operating room flexibility
• AI Data Collection: System records intraoperative data for performance analysis and machine learning optimization

Technical Specifications

Simphoni’s open-console design pairs 7-DOF arms with 3D HD visualization and force feedback, supporting cholecystectomy and gastrointestinal procedures with joystick and foot-pedal control.

Clinical Applications

Simphoni targets general surgery procedures requiring precision and enhanced visualization. The Phase 1 clinical trial at Max Super Specialty Hospital in India (March-May 2023) focused on robotic cholecystectomy, demonstrating:

• Six successful procedures with zero conversions to open surgery
• Minimal blood loss across all cases
• Low postoperative pain scores
• No device-related adverse events

The trial established safety and usability benchmarks, with results published in the Journal of the Society of Laparoscopic & Robotic Surgeons in early 2025. Principal investigator Dr. Bindal and colleagues noted the system performed well across complex procedures with excellent outcomes.

Intended applications include:

• Cholecystectomy
• Gastrointestinal surgery
• General abdominal procedures

Regulatory Status

Borns Medical pursues parallel regulatory submissions in major markets, leveraging clinical evidence from the India trial and planned studies in additional geographies.

Frequently Asked Questions

What surgeries can Simphoni perform?

The Simphoni system is designed for laparoscopic general surgery procedures. Its Phase 1 trial validated performance in cholecystectomy, with broader applications planned for gastrointestinal and abdominal surgery.

How does Simphoni differ from other surgical robots?

Simphoni’s distinguishing feature is its open console design, which maintains surgeon awareness of the operating room environment. Additionally, the system offers force feedback capability and modular compatibility with existing hospital equipment.

When will Simphoni receive regulatory approval?

As of early 2026, Simphoni is in active regulatory pursuit across multiple markets. The company completed its first clinical trial in 2023 and continues building evidence for regulatory submissions.